US Senator

Tammy Baldwin 2025-2026 Regular Session - Authored & Sponsored Legislation

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1002

Introduced
3/12/25  
Deliver for Democracy Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1009

Introduced
3/12/25  
Baltic Security Initiative Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1032

Introduced
3/13/25  
Major Richard Star Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB106

Introduced
1/16/25  
Chiropractic Medicare Coverage Modernization Act of 2025This bill expands Medicare coverage of chiropractic services to include all services provided by chiropractors, rather than only subluxation corrections through manual manipulation of the spine.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB107

Introduced
1/16/25  
Lumbee Fairness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1078

Introduced
3/14/25  
Mississippi River Basin Fishery Commission Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1111

Introduced
3/25/25  
A bill to amend the Internal Revenue Code of 1986 to allow for payments to certain individuals who dye fuel, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1115

Introduced
3/25/25  
Paycheck Fairness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1154

Introduced
3/26/25  
Congressional Whistleblower Protection Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1172

Introduced
3/27/25  
Honor Farmer Contracts Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1186

Introduced
3/27/25  
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1193

Introduced
3/27/25  
America’s Red Rock Wilderness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1227

Introduced
4/1/25  
ABC Act Alleviating Barriers for Caregivers Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1230

Introduced
4/1/25  
SAFETY Act of 2025 Safeguarding American Food and Export Trade Yields Act of 2025

Primary Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1232

Introduced
4/1/25  
Workplace Violence Prevention for Health Care and Social Service Workers Act